Medical Doctor Program year 2021 Source: CMS Open Payments, 2026 publication

Jean Marie Houghton

Gastroenterology Worcester, MA Medical Doctor

NPI 1477536399 CMS profile 293925

55 Lake Ave N, Worcester, MA 01655

Open in the dashboard

General payments

$0

None reported · program year 2021

Research payments

$1,400

Paid to them · 1 record reported · program year 2021

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$97,051 paid to institutions, not to them · program years 2019–2024

Through program year 2021, Jean Marie Houghton of Worcester, MA is reported in the CMS Open Payments database as having received $0 across 0 general payments and $1,400 in research payments paid to them. Separately, studies naming them as principal investigator received $97,051 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 41st percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2021 Research $1,400 1

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

341

Median for Gastroenterology: 569

Drug cost

$8,432

Median for Gastroenterology: $104,976

Branded share of claims

89.1%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates Brand 58 $3,721
Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 119 $1,940
Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 87 $1,543
Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 40 $634
Omeprazole Generic 25 $505
Famotidine Generic 12 $88

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$55,628

Medicare's payments for the services billed

Medicare patients

417

Average age 71

Services billed

574

249 women, 168 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 49%
Depression 37%
Ischemic heart disease 34%
Diabetes 31%
Chronic kidney disease 29%
COPD 25%
Heart failure 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record